Search
for
Sort by
Research 61–90 of 65
- Disorders of excessive hair growth in the adolescent
- Assessment of copper and zinc status in hair and urine of young women descendants of NIDDM parents
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Skin Changes and Its Care in Menopause
- Pattern of body fat distribution in patients of PCOS using DEXA-based indices
- Alopecia Associated with Indinavir Therapy
- Generalized hair loss induced by indinavir plus ritonavir therapy
- Nail, hair and skin hyperpigmentation associated with indinavir therapy
- Osteosclerosis and periostal new bone formation during indinavir therapy
- Hair Biology
- Balint’s syndrome—missed or mistaken?
- Drug Reactions Affecting Hair: Diagnosis
- Drug-Induced Hair Disorders
- Hair Loss Induced by Lopinavir-Ritonavir
- Drug-Induced Skin, Nail and Hair Disorders
- Tinea Capitis: An Overview with Emphasis on Management
- Absorption sites of orally administered drugs in the small intestine
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Hypertensive crisis associated with St. John’s Wort
- Liposomes with an Ethanol Fraction as an Application for Drug Delivery
- Systemic causes of hair loss
- Applications of Nanostructured Lipid Carriers: Recent Advancements and Patent Review
- Stem cell apoptosis in HIV‐1 alopecia
- Progestogens in menopausal hormone therapy
- An overview of management of drug-induced hair and nail disorders
- Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women
- Diseases of the Hair and Nails
- Cutaneous Reactions to Drugs
- Telogen Effluvium
- Cutaneous drug reactions